|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.50 INR | +0.38% |
|
+1.98% | +27.83% |
| Market Cap | 18.52B 196M 172M 158M 148M 278M 282M 1.9B 736M 9.09B 734M 718M 31.58B | P/E 2024 |
22.4x | P/E 2025 | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 18.52B 196M 172M 158M 148M 278M 282M 1.9B 736M 9.09B 734M 718M 31.58B | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 1.45x |
| Free-Float |
57.31% | Yield 2024 * |
-
| Yield 2025 | 0.42% |
| 1 day | +0.38% | ||
| 1 week | +1.98% | ||
| Current month | +21.42% | ||
| 1 month | +20.08% | ||
| 3 months | +43.64% | ||
| 6 months | +26.20% | ||
| Current year | +27.83% |
| 1 week | 48.6 |  | 53.24 |
| 1 month | 41.38 | | 53.66 |
| Current year | 33.05 | | 53.66 |
| 1 year | 33.05 | | 66.4 |
| 3 years | 28.6 | | 100.9 |
| 5 years | 23.6 | | 100.9 |
| 10 years | 7.2 | | 100.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CEO | Chief Executive Officer | 62 | 01/02/1992 |
| Director of Finance/CFO | 59 | 03/04/2002 | |
| Compliance Officer | 40 | 12/11/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 01/02/1992 |
Sanjay Suri
BRD | Director/Board Member | 57 | 13/08/2019 |
| Director/Board Member | 57 | 13/08/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.38% | +1.98% | - | - | 303M | |
| +0.45% | -1.37% | +43.66% | +141.28% | 987B | |
| +3.37% | +1.66% | +58.00% | +44.48% | 576B | |
| +2.07% | +5.52% | +27.75% | +72.72% | 415B | |
| +0.25% | -1.30% | +22.76% | +15.66% | 320B | |
| +2.26% | +2.30% | +30.42% | +18.98% | 278B | |
| +2.61% | +3.11% | +29.81% | +36.09% | 279B | |
| +2.60% | +9.79% | -31.71% | -43.45% | 208B | |
| +0.66% | -0.24% | +27.37% | +52.79% | 187B | |
| +0.14% | -1.71% | +17.76% | +61.42% | 155B | |
| Average | +1.46% | +1.51% | +25.09% | +44.44% | 378.36B | |
| Weighted average by Cap. | +1.56% | +0.73% | +33.29% | +66.37% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.02B 180M 158M 145M 136M 255M 259M 1.75B 676M 8.35B 674M 660M 29.02B | 18.12B 191M 168M 155M 145M 272M 276M 1.86B 720M 8.89B 718M 702M 30.89B |
| Net income | 962M 10.15M 8.92M 8.22M 7.69M 14.41M 14.66M 98.67M 38.19M 472M 38.11M 37.29M 1.64B | 1.18B 12.46M 10.94M 10.09M 9.44M 17.69M 17.99M 121M 46.88M 579M 46.77M 45.76M 2.01B |
| Net Debt | 121M 1.27M 1.12M 1.03M 964K 1.81M 1.84M 12.37M 4.79M 59.14M 4.78M 4.67M 206M | -928K -9.8K -8.61K -7.93K -7.42K -13.91K -14.14K -95.22K -36.86K -455K -36.78K -35.98K -1.58M |
Employees
1,814
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/06/26 | ₹52.50 | +0.38% | 4,377,135 |
| 23/06/26 | ₹52.30 | +4.33% | 18,278,357 |
| 22/06/26 | ₹50.13 | +1.27% | 4,697,621 |
| 19/06/26 | ₹49.50 | -3.00% | 6,160,692 |
| 18/06/26 | ₹51.03 | -0.87% | 5,910,588 |
- Stock Market
- Stocks
- MOREPENLAB Stock
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
